New York, NY, Nov 29 (Bernama-GLOBE NEWSWIRE) --
As blockchain and cryptocurrency companies continue to raise millions
of dollars in funding, there’s an urgent need in the market for
companies and investors to be able to better manage its cryptocurrency
assets with hedging products and tools. Olympus Labs believes that by
offering financial tools and protocol, crypto- based companies and
investors will be able to have more control by protecting their downside
risk in an otherwise extremely volatile market.
“Olympus Labs is an integrator of cryptocurrency-based financial products
(e.g., indices, ETFs, options, futures, etc.). Olympus, third-party
financial product developers, and Fintech applications build the
products which include but are not limited to exchanges, market
analytics tools, payment services, etc. (e.g., Kyber, Shapeshift,
Sentiment),” explains Kai Chen, CEO of Olympus Labs.
On November 27, 2017 due to the high demand from outside investors Olympus Labs opened its doors for its Pre-ICO token sale.
The
Olympus product is viable and has huge long-term potential. As for
competition, it fills an evidently empty space in the cryptocurrency
market, practically guaranteeing that Olympus’ offerings will be
used—and that this usage will generate profits. Olympus’s mission is to
“define the protocol for crypto-based derivatives,” and it seems clear
that these products will help mature the market beyond the current spot
market.
The first of Olympus’s products will allow one to borrow
and lend bitcoin. Cryptocurrency index funds will be the second Olympus
product to hit the market. These index funds will allow investors to
buy into multiple cryptocurrencies at once, with profits moving with the
market as a whole instead of with individual spot cryptocurrencies.
Through customizable fintech-focused smart contracts, exchanges will be
able to quickly and easily make their own indices which track the
overall trend of cryptocurrencies traded on that exchange.
To Participate in the Pre-ICO
The
Olympus Labs Token Sale started at 8 pm (GMT+8/UTC 12pm), 27 November
2017, and ends at 8pm (GMT+8/UTC 12 pm), 3 December 2017.Olympus Presale
terms: Investors contributing more than 100 ETH, will get 10% bonus (1
ETH = 677 Olympus tokens). This will take place after ICO, and those who
passed the KYC process, will be issued MOT, the rest who failed in KYC,
will be refunded with ETH. For additional information and terms of the
sale please visit the Olympus Labs website.
During the registration period (27 November 2017 to 3 December 2017), please visit https://kyc.olympuslabs.io/.
Note: Information regarding the token sale will ONLY be disseminated on our official communication channels: our official website and our official telegram group.
About OLYMPUS LABS
Olympus
is led by a cohesive team with extensive expertise in both the
traditional financial markets and blockchain technology. Olympus Founder
and CEO Kai Chen started his career on Wall Street with Morgan Stanley,
and he later went on to work for McKinsey and PIMCO. Our development
team includes Google’s former development community lead for China. On
the business side, we have Danielle Sabrina, a highly sought-after
marketing expert and veteran of several successful ICOs, and has helped
her clients achieve prestigious awards such as Inc 500, Forbes Next
Billion Dollar Startup, Entrepreneur 360 among other top level
recognition. Danielle’s work has also been featured in Huffington Post
and Entrepreneur. Olympus also has a strong advising board made up of
former executives at Morgan Stanley and McKinsey.
OLYMPUS LABS Social Media
For more information about Olympus Labs and the launch of the pre-ICO, please visit https://olympuslabs.io/web; on Twitter @olympuslabsbc and Telegram at https://t.me/olympuslabs.
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a88937da-05db-437e-92f0-07cc02b4dd8f
Danielle Sabrina
Olympus Labs
pr@oympuslabs.io
Sharde' Brown
What Vibes Your Tribe
press@wvytmedia.com
SOURCE : Olympus Labs
No comments:
Post a Comment